Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells

Oncogene

Volumn 25, Issue 19, 2006, Pages 2795-2800

  Kreppel, M ^a   Aryee, D N T ^a   Schaefern, K L ^b   Amann, G ^c   Kofler, R ^d   Poremba, C ^b   Kovar, H ^a  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

CD99; Ewing's sarcoma; EWS FL11; Ion channels; Migration

Indexed keywords

CD99 ANTIGEN; CELL PROTEIN; CELL SURFACE PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; POTASSIUM CHANNEL MODULATORY FACTOR; PROTEIN KCMF1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL AGGREGATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EWING SARCOMA; EWS GENE; GENE; GENE REARRANGEMENT; GENE REPRESSION; GENE SILENCING; GROWTH INHIBITION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; METASTASIS INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS; TRANSCRIPTION REGULATION;

ANTIGENS, CD; BONE NEOPLASMS; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, SMALL INTERFERING; SARCOMA, EWING'S; TUMOR CELLS, CULTURED; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 33646544722     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209300     Document Type: Article

References (31)

1. Alberti I, Bernard G, Rouquette-Jazdanian AK, Pelassy C, Pourtein M, Aussel C et al. (2002). FASEB J 16: 1946-1948.
2. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer Kuntschik M. (1991). Cancer 67: 1886-1893.
3. Arvand A, Denny CT. (2001). Oncogene 20: 5747-5754.
4. Bernard G, Breittmayer JP, de Matteis M, Trampont P, Hofman P, Senik A et al. (1997). J Immunol 158: 2543-2550.
5. Bernard G, Zoccola D, Deckert M, Breittmayer JP, Aussel C, Bernard A. (1995). J Immunol 154: 26-32.
6. Bertaux K, Broux O, Chauveau C, Jeanfils J, Devedjian JC. (2005). J Bone Miner Metab 23: 114-122.
7. Cerisano V, Aalto Y, Perdichizzi S, Bernard G, Manara MC, Benini S et al. (2004). Oncogene 23: 5664-5674.
8. Choi EY, Park WS, Jung KC, Kim SH, Kim YY, Lee WJ et al. (1998). J Immunol 161: 749-754.
9. Conti M. (2004). J Exp Ther Oncol 4: 161-166.
10. Dworzak MN, Fritsch G, Buchinger P, Fleischer C, Printz D, Zellner A et al. (1994). Blood 83: 415-425.
11. Dworzak MN, Fritsch G, Fleischer C, Printz D, Froschl G, Buchinger P et al. (1999). Br J Haematol 105: 690-695.
12. Fellinger EJ, Garin Chesa P, Triche TJ, Huvos AG, Rettig WJ. (1991). Am J Pathol 139: 317-325.
13. Gelin C, Aubrit F, Phalipon A, Raynal B, Cole S, Kaczorek M et al. (1989). EMBO J 8: 3253-3259.
14. Goodfellow PN, Pym B, Pritchard C, Ellis N, Palmer M, Smith M et al. (1988). Philos Trans R Soc Lond B Biol Sci 322: 145-154.
15. Hahn JH, Kim MK, Choi EY, Kim SH, Sohn HW, Ham DI et al. (1997). J Immunol 159: 2250-2258.
16. Hahn MJ, Yoon SS, Sohn HW, Song HG, Park SH, Kim TJ. (2000). FEBS Lett 470: 350-354.
17. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ. (2005). Cancer Res 65: 4633-4644.
18. Jang JH. (2004). FEBS Lett 578: 21-25.
19. Kasinrerk W, Tokrasinwit N, Moonsom S, Stockinger H. (2000). Immunol Lett 71: 33-41.
20. Kim SH, Choi EY, Shin YK, Kim TJ, Chung DH, Chane SI et al. (1998). Blood 92: 4287-4295.
21. Kim SH, Shin YK, Lee IS, Bae YM, Sohn HW, Suh YH et al. (2000). Blood 95: 294-300.
22. Kovar H, Dworzak M, Strehl S, Schnell E, Ambros IM, Ambras PF et al. (1990). Oncogene 5: 1067-1070.
23. Lee YS, Sayeed MM, Wurster RD. (1993). Cell Signal 5: 803-809.
24. Li Z, Stuart RO, Eraly SA, Gittes G, Beier DR, Nigam SK. (2003). Biochem Biophys Res Commun 306: 623-628.
25. Park SH, Shin YK, Suh YH, Park WS, Ban YL, Choi HS et al. (2005). Gene 353: 177-188.
26. Rorie CJ, Thomas VD, Chen P, Pierce HH, O'Bryan JP, Weissman BE. (2004). Cancer Res 64: 1266-1277.
27. Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA. (2002). Nat Immunol 3: 143-150.
28. Scotlandi K, Baldini N, Cerisano V, Manara MC, Benini S, Serra M et al. (2000). Cancer Res 60: 5134-5142.
29. Sohn HW, Choi EY, Kim SH, Lee IS, Chung DH, Sung UA et al. (1998). Am J Pathol 153: 1937-1945.
30. Sohn HW, Shin YK, Lee IS, Bae YM, Suh YH, Kim MK et al. (2001). J Immunol 166: 787-794.
31. Waclavicek M, Majdic O, Stulnig T, Berger M, Sunder-Plassmann R, Zlabinger GJ et al. (1998). J Immunol 161: 4671-4678.